Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice
Studies showed the positive effects of omega-3 fatty acid (n-3 FA) for the treatment of inflammatory bowel disease as it alleviated the symptoms and promoted better mucosal integrity. The objective of this study was to determine whether a diet with the addition of n-3 FA helps control the inflammati...
Saved in:
Published in | Lipids in health and disease Vol. 14; no. 1; p. 54 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
12.06.2015
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Studies showed the positive effects of omega-3 fatty acid (n-3 FA) for the treatment of inflammatory bowel disease as it alleviated the symptoms and promoted better mucosal integrity. The objective of this study was to determine whether a diet with the addition of n-3 FA helps control the inflammation observed in 5-fluorouracil (5-FU) induced mucositis.
BALB/c mice were randomly divided into four groups as follows: 1: control (CTL), fed a standard chow diet; 2: CTL + n-3 FA - n-3 FA, fed a diet with n-3; 3: mucositis (MUC), fed a standard chow diet and subjected to mucositis; and 4: MUC+ n-3 FA, fed a diet with n-3 FA and subjected to mucositis. On the 8th day, the animals of the MUC and MUC + n-3 FA groups received an intraperitoneal injection of 300 mg/kg 5-FU for mucositis induction. After 24 h or 72 h, all mice were euthanized and evaluated for intestinal permeability, bacterial translocation, intestinal histology and apoptosis.
Mice that received the diet with n-3 FA and a 5-FU injection showed less weight loss compared to the animals of the MUC group (p < 0.005). Decreased intestinal permeability and bacterial translocation were also observed in animals fed n-3 FA, and these mice underwent mucositis compared to the MUC group (p < 0.005). These data were associated with mucosal integrity and a reduced number of apoptotic cells in the ileum mucosa compared to the mice that received the control diet and 5-FU injection.
Together, these results show that omega-3 fatty acid decreases the mucosal damage caused by 5-FU-induced mucositis. |
---|---|
AbstractList | Background Studies showed the positive effects of omega-3 fatty acid (n-3 FA) for the treatment of inflammatory bowel disease as it alleviated the symptoms and promoted better mucosal integrity. The objective of this study was to determine whether a diet with the addition of n-3 FA helps control the inflammation observed in 5-fluorouracil (5-FU) induced mucositis. Methods BALB/c mice were randomly divided into four groups as follows: 1: control (CTL), fed a standard chow diet; 2: CTL + n-3 FA - n-3 FA, fed a diet with n-3; 3: mucositis (MUC), fed a standard chow diet and subjected to mucositis; and 4: MUC+ n-3 FA, fed a diet with n-3 FA and subjected to mucositis. On the 8.sup.th day, the animals of the MUC and MUC + n-3 FA groups received an intraperitoneal injection of 300 mg/kg 5-FU for mucositis induction. After 24 h or 72 h, all mice were euthanized and evaluated for intestinal permeability, bacterial translocation, intestinal histology and apoptosis. Results Mice that received the diet with n-3 FA and a 5-FU injection showed less weight loss compared to the animals of the MUC group (p < 0.005). Decreased intestinal permeability and bacterial translocation were also observed in animals fed n-3 FA, and these mice underwent mucositis compared to the MUC group (p < 0.005). These data were associated with mucosal integrity and a reduced number of apoptotic cells in the ileum mucosa compared to the mice that received the control diet and 5-FU injection. Conclusion Together, these results show that omega-3 fatty acid decreases the mucosal damage caused by 5-FU-induced mucositis. Keywords: Omega-3 fatty acid, Mucositis, Intestinal damage Studies showed the positive effects of omega-3 fatty acid (n-3 FA) for the treatment of inflammatory bowel disease as it alleviated the symptoms and promoted better mucosal integrity. The objective of this study was to determine whether a diet with the addition of n-3 FA helps control the inflammation observed in 5-fluorouracil (5-FU) induced mucositis. BALB/c mice were randomly divided into four groups as follows: 1: control (CTL), fed a standard chow diet; 2: CTL + n-3 FA - n-3 FA, fed a diet with n-3; 3: mucositis (MUC), fed a standard chow diet and subjected to mucositis; and 4: MUC+ n-3 FA, fed a diet with n-3 FA and subjected to mucositis. On the 8th day, the animals of the MUC and MUC + n-3 FA groups received an intraperitoneal injection of 300 mg/kg 5-FU for mucositis induction. After 24 h or 72 h, all mice were euthanized and evaluated for intestinal permeability, bacterial translocation, intestinal histology and apoptosis. Mice that received the diet with n-3 FA and a 5-FU injection showed less weight loss compared to the animals of the MUC group (p < 0.005). Decreased intestinal permeability and bacterial translocation were also observed in animals fed n-3 FA, and these mice underwent mucositis compared to the MUC group (p < 0.005). These data were associated with mucosal integrity and a reduced number of apoptotic cells in the ileum mucosa compared to the mice that received the control diet and 5-FU injection. Together, these results show that omega-3 fatty acid decreases the mucosal damage caused by 5-FU-induced mucositis. Studies showed the positive effects of omega-3 fatty acid (n-3 FA) for the treatment of inflammatory bowel disease as it alleviated the symptoms and promoted better mucosal integrity. The objective of this study was to determine whether a diet with the addition of n-3 FA helps control the inflammation observed in 5-fluorouracil (5-FU) induced mucositis. BALB/c mice were randomly divided into four groups as follows: 1: control (CTL), fed a standard chow diet; 2: CTL + n-3 FA - n-3 FA, fed a diet with n-3; 3: mucositis (MUC), fed a standard chow diet and subjected to mucositis; and 4: MUC+ n-3 FA, fed a diet with n-3 FA and subjected to mucositis. On the 8.sup.th day, the animals of the MUC and MUC + n-3 FA groups received an intraperitoneal injection of 300 mg/kg 5-FU for mucositis induction. After 24 h or 72 h, all mice were euthanized and evaluated for intestinal permeability, bacterial translocation, intestinal histology and apoptosis. Mice that received the diet with n-3 FA and a 5-FU injection showed less weight loss compared to the animals of the MUC group (p < 0.005). Decreased intestinal permeability and bacterial translocation were also observed in animals fed n-3 FA, and these mice underwent mucositis compared to the MUC group (p < 0.005). These data were associated with mucosal integrity and a reduced number of apoptotic cells in the ileum mucosa compared to the mice that received the control diet and 5-FU injection. Together, these results show that omega-3 fatty acid decreases the mucosal damage caused by 5-FU-induced mucositis. |
ArticleNumber | 54 |
Audience | Academic |
Author | Rodrigues, Núbia Morais Generoso, Simone de Vasconcelos Maioli, Tatiani Uceli Paiva, Nivea Carolina Cardoso, Valbert Nascimento Faria, Ana Maria Caetano Carneiro, Cláudia Martins Trindade, Luísa Martins Ferreira, Adaliene Versiani de Matos |
Author_xml | – sequence: 1 givenname: Simone de Vasconcelos surname: Generoso fullname: Generoso, Simone de Vasconcelos email: simonenutufmg@gmail.com organization: Departamento de Nutrição, Escola de Enfermagem, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. simonenutufmg@gmail.com – sequence: 2 givenname: Núbia Morais surname: Rodrigues fullname: Rodrigues, Núbia Morais email: nubia_mrodrigues@hotmail.com organization: Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. nubia_mrodrigues@hotmail.com – sequence: 3 givenname: Luísa Martins surname: Trindade fullname: Trindade, Luísa Martins email: luisatrindade2009@yahoo.com.br organization: Departamento de Nutrição, Escola de Enfermagem, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. luisatrindade2009@yahoo.com.br – sequence: 4 givenname: Nivea Carolina surname: Paiva fullname: Paiva, Nivea Carolina email: niviacarolina@yahoo.com.br organization: Núcleo de Pesquisa em Ciências Biológicas, Instituto de Ciências Exatas e Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Brazil. niviacarolina@yahoo.com.br – sequence: 5 givenname: Valbert Nascimento surname: Cardoso fullname: Cardoso, Valbert Nascimento email: valbertcardoso@yahoo.com.br organization: Departamento de Análises Clínicas e Toxicológicas, Escola de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. valbertcardoso@yahoo.com.br – sequence: 6 givenname: Cláudia Martins surname: Carneiro fullname: Carneiro, Cláudia Martins email: claudiamartinscarneiro@gmail.com organization: Núcleo de Pesquisa em Ciências Biológicas, Instituto de Ciências Exatas e Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Brazil. claudiamartinscarneiro@gmail.com – sequence: 7 givenname: Adaliene Versiani de Matos surname: Ferreira fullname: Ferreira, Adaliene Versiani de Matos email: adaliene@gmail.com organization: Departamento de Nutrição, Escola de Enfermagem, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. adaliene@gmail.com – sequence: 8 givenname: Ana Maria Caetano surname: Faria fullname: Faria, Ana Maria Caetano email: afaria@ufmg.icb.br organization: Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. afaria@ufmg.icb.br – sequence: 9 givenname: Tatiani Uceli surname: Maioli fullname: Maioli, Tatiani Uceli email: tatianimaioli@gmail.com organization: Departamento de Nutrição, Escola de Enfermagem, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. tatianimaioli@gmail.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26063053$$D View this record in MEDLINE/PubMed |
BookMark | eNptUV1LHDEUDWLxq_6AvpRAn7Pm5mt2XgpiWxWEvij0LWQzN2vKzGSZZCr66xtZXRQkgVzOPeeQwzkm-2MakZAvwBcAS3OWQbRKMQ6aca4Fe9ojR6AawzTAn_038yE5zvkv54I3xhyQQ2G4kVzLI-J_RCxueqR53mx6HHAsrsQ00odY7mkacO2YpMGV8kidjx2tE46zK5ipZqGf05TmqW56Gsdu9tjRYfYpxxJzRegQPX4mn4LrM56-vCfk7tfP24srdvP78vri_IZ5LU1hbes5CgO4ksKEgN1ypZoGGqeCxLbCQRsOS2ek4ELDynVN8KKrVzhUBuQJ-b713cyrATtfs0yut5spDjWhTS7a95sx3tt1-meVauRSNNXg29Zg7Xq0cQyp0vwQs7fnWoFqAYysrMUHrHo6rGlrQyFW_J0AtgI_pZwnDLsvAbfPRdptkbYWaZ-LtE9V8_Vtlp3itTn5H6hVnUg |
CitedBy_id | crossref_primary_10_1007_s15010_018_1178_5 crossref_primary_10_1371_journal_pone_0236300 crossref_primary_10_1016_j_jff_2024_106096 crossref_primary_10_3390_ph13010010 crossref_primary_10_1016_j_biopha_2021_112414 crossref_primary_10_1080_01635581_2020_1759659 crossref_primary_10_1080_01635581_2016_1225100 crossref_primary_10_1016_j_biopha_2018_04_133 crossref_primary_10_1016_j_biopha_2020_111152 crossref_primary_10_1007_s42770_023_00928_0 crossref_primary_10_3390_nu14193998 crossref_primary_10_3389_fimmu_2017_01331 crossref_primary_10_5582_ddt_2016_01059 crossref_primary_10_1097_HEP_0000000000000406 crossref_primary_10_29413_ABS_2024_9_2_3 crossref_primary_10_1016_j_anifeedsci_2017_04_022 crossref_primary_10_1155_2017_6869259 crossref_primary_10_3920_BM2017_0082 crossref_primary_10_1111_bph_14883 crossref_primary_10_3390_microorganisms10051050 crossref_primary_10_3390_ijms21093066 crossref_primary_10_1016_j_tifs_2021_05_001 crossref_primary_10_1080_01635581_2018_1521439 crossref_primary_10_1016_j_pharmthera_2024_108689 crossref_primary_10_1007_s00280_016_3150_3 crossref_primary_10_1016_j_reval_2018_03_009 crossref_primary_10_3389_fmicb_2017_00800 |
Cites_doi | 10.1111/j.1469-0691.2012.03879.x 10.1111/j.1365-2249.2009.04020.x 10.1007/s00280-008-0715-9 10.1016/S0969-8043(98)00185-7 10.1080/01635580802192841 10.1152/ajprenal.00637.2009 10.1039/c3fo60036j 10.1093/jn/123.11.1939 10.3945/jn.113.178178 10.3109/09553002.2014.954059 10.1111/jre.12264 10.1016/j.pharmthera.2013.10.010 10.1177/0148607114567508 10.1016/j.chroma.2007.01.062 10.4049/jimmunol.1101305 10.1186/1477-5751-13-6 10.1111/joim.12217 10.1017/S0007114512000542 10.1016/j.atherosclerosis.2010.05.022 10.1002/cncr.28592 10.1159/000228994 10.1042/bse0390025 10.1177/007327538202000401 10.4049/jimmunol.1402481 10.1002/hed.10326 10.1097/CCO.0b013e3281214412 10.1159/000368714 10.3945/an.111.000893 10.1016/0003-2697(78)90046-5 10.1046/j.1440-1746.2001.02537.x 10.12998/wjcc.v2.i7.250 10.1017/S0007114514000701 10.1371/journal.pone.0028862 10.1016/j.fct.2013.11.051 10.1007/s00383-012-3144-0 10.1007/s00520-006-0176-9 10.1073/pnas.1322691111 10.1038/nrc1318 10.1007/s00520-014-2137-z 10.1016/j.clnu.2011.05.002 10.1038/nrc1074 10.1093/carcin/bgu068 10.1080/01635581.2015.1004730 10.1097/MIB.0000000000000204 10.1016/j.nut.2009.04.005 10.1016/j.clnu.2013.09.003 10.1016/S1368-8375(02)00033-7 10.3390/nu2030355 10.1007/s11745-012-3680-3 10.1186/1476-511X-13-146 10.1007/s10695-007-9152-7 10.1258/ebm.2012.012260 10.1111/j.1753-4887.2010.00287.x 10.1079/NRR2005113 10.1007/s00520-006-0055-4 10.1016/0163-7258(90)90056-8 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2015 BioMed Central Ltd. Generoso et al. 2015 |
Copyright_xml | – notice: COPYRIGHT 2015 BioMed Central Ltd. – notice: Generoso et al. 2015 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1186/s12944-015-0052-z |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1476-511X |
ExternalDocumentID | A541491163 10_1186_s12944_015_0052_z 26063053 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -A0 0R~ 29L 2WC 3V. 4.4 53G 5GY 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAHBH AAJSJ ABDBF ABUWG ACGFO ACGFS ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESTFP ESX F5P FRP FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HH5 HMCUK HYE IAO IGS IHR INH INR ITC KQ8 LK8 M1P M48 M7P M~E NPM O5R O5S OK1 P2P P6G PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX CITATION AFGXO 5PM |
ID | FETCH-LOGICAL-c536t-99c0e261eb326ffed8b47717a4f3e91ebf56018a6320251bad7fc2dc2d2ae4613 |
IEDL.DBID | RPM |
ISSN | 1476-511X |
IngestDate | Tue Sep 17 21:06:40 EDT 2024 Wed Aug 14 18:53:08 EDT 2024 Tue Nov 12 23:34:29 EST 2024 Thu Sep 12 16:21:08 EDT 2024 Sat Sep 28 07:56:17 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c536t-99c0e261eb326ffed8b47717a4f3e91ebf56018a6320251bad7fc2dc2d2ae4613 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473827/ |
PMID | 26063053 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4473827 gale_infotracmisc_A541491163 gale_infotracacademiconefile_A541491163 crossref_primary_10_1186_s12944_015_0052_z pubmed_primary_26063053 |
PublicationCentury | 2000 |
PublicationDate | 2015-Jun-12 2015-06-12 20150612 |
PublicationDateYYYYMMDD | 2015-06-12 |
PublicationDate_xml | – month: 06 year: 2015 text: 2015-Jun-12 day: 12 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Lipids in health and disease |
PublicationTitleAlternate | Lipids Health Dis |
PublicationYear | 2015 |
Publisher | BioMed Central Ltd BioMed Central |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
References | 24615748 - Cancer. 2014 May 15;120(10):1453-61 21724996 - J Immunol. 2011 Aug 15;187(4):1957-69 25222662 - Inflamm Bowel Dis. 2014 Dec;20(12):2394-404 22648862 - Lipids. 2012 Jul;47(7):669-78 25200333 - Lipids Health Dis. 2014;13:146 22254027 - Nutrients. 2010 Mar;2(3):355-74 23479757 - Exp Biol Med (Maywood). 2013 Jan;238(1):1-6 25589072 - J Immunol. 2015 Feb 15;194(4):1983-95 24721659 - J Negat Results Biomed. 2014;13:6 20500789 - Nutr Rev. 2010 May;68(5):280-9 18649029 - Fish Physiol Biochem. 2008 Jun;34(2):117-27 24316316 - Food Chem Toxicol. 2014 Feb;64:275-80 17564153 - J Support Oncol. 2007 May;5(5):231-5 10376319 - Appl Radiat Isot. 1999 Jul;51(1):33-6 12509961 - Oral Oncol. 2003 Feb;39(2):91-100 23864512 - J Nutr. 2013 Sep;143(9):1501-8 19660909 - Nutrition. 2010 Feb;26(2):218-23 25040088 - Aliment Pharmacol Ther. 2014 Sep;40(5):409-21 727482 - Anal Biochem. 1978 Oct 1;90(1):420-6 25032198 - World J Clin Cases. 2014 Jul 16;2(7):250-2 8229312 - J Nutr. 1993 Nov;123(11):1939-51 20542512 - Atherosclerosis. 2010 Sep;212(1):252-9 25712760 - J Periodontal Res. 2015 Dec;50(6):775-85 22524597 - Clin Microbiol Infect. 2013 May;19(5):474-9 25131937 - Int J Radiat Biol. 2015 Feb;91(2):150-6 11446882 - J Gastroenterol Hepatol. 2001 Jul;16(7):748-54 14724910 - Head Neck. 2004 Jan;26(1):77-84 21632157 - Clin Nutr. 2011 Oct;30(5):678-87 15057287 - Nat Rev Cancer. 2004 Apr;4(4):277-84 24095638 - Clin Nutr. 2014 Aug;33(4):694-701 22907722 - Pediatr Surg Int. 2012 Sep;28(9):913-8 22332096 - Adv Nutr. 2012 Jan;3(1):1-7 25803482 - Nutr Cancer. 2015;67(3):486-93 19752534 - Ann Nutr Metab. 2009;55(1-3):8-43 14585072 - Essays Biochem. 2003;39:25-40 20844021 - Am J Physiol Renal Physiol. 2010 Dec;299(6):F1451-61 18324404 - Cancer Chemother Pharmacol. 2008 Dec;63(1):91-8 19793338 - Clin Exp Immunol. 2009 Dec;158(3):325-33 22456439 - Br J Nutr. 2013 Jan 14;109(1):89-98 22194930 - PLoS One. 2011;6(12):e28862 25493082 - Case Rep Oncol. 2014 Oct 22;7(3):692-9 24641624 - J Intern Med. 2014 Nov;276(5):498-511 19079874 - Nutr Res Rev. 2006 Jun;19(1):26-52 11611111 - Hist Sci. 1982 Dec;50(4):235-66 12724731 - Nat Rev Cancer. 2003 May;3(5):330-8 17545794 - Curr Opin Oncol. 2007 Jul;19(4):323-7 24500789 - Support Care Cancer. 2014 Jun;22(6):1647-54 23014495 - J Nutr. 2012 Nov;142(11):2017-24 24201219 - Pharmacol Ther. 2014 Mar;141(3):272-82 24775220 - Br J Nutr. 2014 Jul 28;112(2):145-53 23660640 - Food Funct. 2013 Jun;4(6):923-31 16601950 - Support Care Cancer. 2006 Jun;14(6):505-15 24632492 - Carcinogenesis. 2014 Jul;35(7):1613-9 25573703 - JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):279-86 24469832 - Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):E702-11 17275831 - J Chromatogr A. 2007 Mar 23;1145(1-2):222-8 1707544 - Pharmacol Ther. 1990;48(3):381-95 19005975 - Nutr Cancer. 2008;60(6):757-67 52_CR28 52_CR25 52_CR26 52_CR24 S Tanaka (52_CR18) 2001; 16 A Ibrahim (52_CR6) 2011; 30 MS Izquierdo (52_CR57) 2008; 34 WMN Ratnayake (52_CR1) 2009; 55 P Beguin (52_CR34) 2013; 4 M Barone (52_CR42) 2014; 35 CL Smith (52_CR46) 2008; 60 GC Burdge (52_CR5) 2006; 19 SOF Diniz (52_CR59) 1999; 51 S Taneda (52_CR40) 2010; 299 MA El-Ghazaly (52_CR49) 2015; 91 Y Touchefeu (52_CR31) 2014; 40 PCL Leocádio (52_CR43) 2015; 67 Y Liu (52_CR8) 2012 AL Cawood (52_CR19) 2010; 212 S Beutheu (52_CR44) 2014; 33 B Zhivotovsky (52_CR39) 2003; 39 AF Bento (52_CR7) 2011; 187 F Destaillats (52_CR56) 2007; 1145 DB Longley (52_CR14) 2003; 3 S-B Fang (52_CR47) 2014; 22 TU Maioli (52_CR16) 2014; 13 JR Christie (52_CR55) 1982; 50 C Gudiol (52_CR29) 2013; 19 Y Li (52_CR35) 2014; 13 R Sun (52_CR51) 2014; 112 52_CR48 52_CR45 A Farrukh (52_CR50) 2014; 2 TM Ferreira (52_CR21) 2012; 47 ML Viana (52_CR58) 2010; 26 52_CR9 A Hara (52_CR54) 1978; 90 ST Sonis (52_CR15) 2004; 4 52_CR2 S Iyama (52_CR30) 2014; 7 M Frank (52_CR38) 2015; 194 52_CR4 JA Jones (52_CR10) 2006; 14 52_CR3 T Koppelmann (52_CR22) 2013; 109 DM Keefe (52_CR12) 2007; 19 DW Thorpe (52_CR23) 2013; 238 N Kanarek (52_CR27) 2014; 111 PG Reeves (52_CR53) 1993; 123 52_CR13 MCW Myhrstad (52_CR41) 2014; 276 52_CR11 JM Monk (52_CR32) 2013; 143 CM Yates (52_CR17) 2014; 141 WB Parker (52_CR37) 1990; 48 H Matsunaga (52_CR33) 2009; 158 52_CR52 M Sun (52_CR36) 2014; 64 PMG Soares (52_CR20) 2008; 63 |
References_xml | – volume: 19 start-page: 474 year: 2013 ident: 52_CR29 publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2012.03879.x contributor: fullname: C Gudiol – volume: 158 start-page: 325 year: 2009 ident: 52_CR33 publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2009.04020.x contributor: fullname: H Matsunaga – volume: 63 start-page: 91 year: 2008 ident: 52_CR20 publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-008-0715-9 contributor: fullname: PMG Soares – volume: 51 start-page: 33 year: 1999 ident: 52_CR59 publication-title: Appl Radiat Isot doi: 10.1016/S0969-8043(98)00185-7 contributor: fullname: SOF Diniz – volume: 60 start-page: 757 year: 2008 ident: 52_CR46 publication-title: Nutr Cancer doi: 10.1080/01635580802192841 contributor: fullname: CL Smith – volume: 299 start-page: F1451 year: 2010 ident: 52_CR40 publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00637.2009 contributor: fullname: S Taneda – volume: 4 start-page: 923 year: 2013 ident: 52_CR34 publication-title: Food Funct doi: 10.1039/c3fo60036j contributor: fullname: P Beguin – volume: 123 start-page: 1939 year: 1993 ident: 52_CR53 publication-title: J Nutr doi: 10.1093/jn/123.11.1939 contributor: fullname: PG Reeves – volume: 143 start-page: 1501 year: 2013 ident: 52_CR32 publication-title: J Nutr doi: 10.3945/jn.113.178178 contributor: fullname: JM Monk – volume: 91 start-page: 150 year: 2015 ident: 52_CR49 publication-title: Int J Radiat Biol doi: 10.3109/09553002.2014.954059 contributor: fullname: MA El-Ghazaly – ident: 52_CR48 doi: 10.1111/jre.12264 – volume: 40 start-page: 409 year: 2014 ident: 52_CR31 publication-title: Aliment Pharmacol Ther contributor: fullname: Y Touchefeu – volume: 141 start-page: 272 year: 2014 ident: 52_CR17 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2013.10.010 contributor: fullname: CM Yates – ident: 52_CR45 doi: 10.1177/0148607114567508 – volume: 1145 start-page: 222 year: 2007 ident: 52_CR56 publication-title: J Chromatogr A doi: 10.1016/j.chroma.2007.01.062 contributor: fullname: F Destaillats – volume: 187 start-page: 1957 year: 2011 ident: 52_CR7 publication-title: J Immunol doi: 10.4049/jimmunol.1101305 contributor: fullname: AF Bento – volume: 13 start-page: 6 year: 2014 ident: 52_CR16 publication-title: J Negat Results Biomed doi: 10.1186/1477-5751-13-6 contributor: fullname: TU Maioli – volume: 276 start-page: 498 year: 2014 ident: 52_CR41 publication-title: J Intern Med doi: 10.1111/joim.12217 contributor: fullname: MCW Myhrstad – ident: 52_CR25 doi: 10.1017/S0007114512000542 – volume: 212 start-page: 252 year: 2010 ident: 52_CR19 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2010.05.022 contributor: fullname: AL Cawood – ident: 52_CR9 doi: 10.1002/cncr.28592 – volume: 55 start-page: 8 year: 2009 ident: 52_CR1 publication-title: Ann Nutr Metab doi: 10.1159/000228994 contributor: fullname: WMN Ratnayake – volume: 39 start-page: 25 year: 2003 ident: 52_CR39 publication-title: Essays Biochem doi: 10.1042/bse0390025 contributor: fullname: B Zhivotovsky – volume: 50 start-page: 235 year: 1982 ident: 52_CR55 publication-title: Hist Sci doi: 10.1177/007327538202000401 contributor: fullname: JR Christie – volume-title: Fish Oil Enhances Intestinal Integrity and Inhibits TLR4 and NOD2 Signaling Pathways in Weaned Pigs after LPS Challenge 1–3 year: 2012 ident: 52_CR8 contributor: fullname: Y Liu – volume: 194 start-page: 1983 year: 2015 ident: 52_CR38 publication-title: J Immunol doi: 10.4049/jimmunol.1402481 contributor: fullname: M Frank – ident: 52_CR26 doi: 10.1002/hed.10326 – volume: 19 start-page: 323 year: 2007 ident: 52_CR12 publication-title: Curr Opin Oncol doi: 10.1097/CCO.0b013e3281214412 contributor: fullname: DM Keefe – volume: 7 start-page: 692 year: 2014 ident: 52_CR30 publication-title: Case Rep Oncol doi: 10.1159/000368714 contributor: fullname: S Iyama – ident: 52_CR52 doi: 10.3945/an.111.000893 – volume: 90 start-page: 420 year: 1978 ident: 52_CR54 publication-title: Anal Biochem doi: 10.1016/0003-2697(78)90046-5 contributor: fullname: A Hara – volume: 16 start-page: 748 year: 2001 ident: 52_CR18 publication-title: J Gastroenterol Hepatol doi: 10.1046/j.1440-1746.2001.02537.x contributor: fullname: S Tanaka – volume: 2 start-page: 250 year: 2014 ident: 52_CR50 publication-title: World J Clin cases doi: 10.12998/wjcc.v2.i7.250 contributor: fullname: A Farrukh – volume: 112 start-page: 145 year: 2014 ident: 52_CR51 publication-title: Br J Nutr doi: 10.1017/S0007114514000701 contributor: fullname: R Sun – ident: 52_CR24 doi: 10.1371/journal.pone.0028862 – volume: 64 start-page: 275 year: 2014 ident: 52_CR36 publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2013.11.051 contributor: fullname: M Sun – ident: 52_CR4 doi: 10.1007/s00383-012-3144-0 – ident: 52_CR11 doi: 10.1007/s00520-006-0176-9 – volume: 111 start-page: E702 year: 2014 ident: 52_CR27 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1322691111 contributor: fullname: N Kanarek – volume: 4 start-page: 277 year: 2004 ident: 52_CR15 publication-title: Nat Rev Cancer doi: 10.1038/nrc1318 contributor: fullname: ST Sonis – volume: 22 start-page: 1647 year: 2014 ident: 52_CR47 publication-title: Support Care Cancer doi: 10.1007/s00520-014-2137-z contributor: fullname: S-B Fang – volume: 30 start-page: 678 year: 2011 ident: 52_CR6 publication-title: Clin Nutr doi: 10.1016/j.clnu.2011.05.002 contributor: fullname: A Ibrahim – volume: 3 start-page: 330 year: 2003 ident: 52_CR14 publication-title: Nat Rev Cancer doi: 10.1038/nrc1074 contributor: fullname: DB Longley – volume: 35 start-page: 1613 year: 2014 ident: 52_CR42 publication-title: Carcinogenesis doi: 10.1093/carcin/bgu068 contributor: fullname: M Barone – volume: 67 start-page: 486 year: 2015 ident: 52_CR43 publication-title: Nutr Cancer doi: 10.1080/01635581.2015.1004730 contributor: fullname: PCL Leocádio – ident: 52_CR28 doi: 10.1097/MIB.0000000000000204 – volume: 26 start-page: 218 year: 2010 ident: 52_CR58 publication-title: Nutrition doi: 10.1016/j.nut.2009.04.005 contributor: fullname: ML Viana – volume: 33 start-page: 694 year: 2014 ident: 52_CR44 publication-title: Clin Nutr doi: 10.1016/j.clnu.2013.09.003 contributor: fullname: S Beutheu – ident: 52_CR13 doi: 10.1016/S1368-8375(02)00033-7 – ident: 52_CR3 doi: 10.3390/nu2030355 – volume: 47 start-page: 669 year: 2012 ident: 52_CR21 publication-title: Lipids doi: 10.1007/s11745-012-3680-3 contributor: fullname: TM Ferreira – volume: 13 start-page: 146 year: 2014 ident: 52_CR35 publication-title: Lipids Health Dis doi: 10.1186/1476-511X-13-146 contributor: fullname: Y Li – volume: 34 start-page: 117 year: 2008 ident: 52_CR57 publication-title: Fish Physiol Biochem doi: 10.1007/s10695-007-9152-7 contributor: fullname: MS Izquierdo – volume: 109 start-page: 89 year: 2013 ident: 52_CR22 publication-title: Br J Nutr doi: 10.1017/S0007114512000542 contributor: fullname: T Koppelmann – volume: 238 start-page: 1 year: 2013 ident: 52_CR23 publication-title: Exp Biol Med (Maywood) doi: 10.1258/ebm.2012.012260 contributor: fullname: DW Thorpe – ident: 52_CR2 doi: 10.1111/j.1753-4887.2010.00287.x – volume: 19 start-page: 26 year: 2006 ident: 52_CR5 publication-title: Nutr Res Rev doi: 10.1079/NRR2005113 contributor: fullname: GC Burdge – volume: 14 start-page: 505 year: 2006 ident: 52_CR10 publication-title: Support Care Cancer doi: 10.1007/s00520-006-0055-4 contributor: fullname: JA Jones – volume: 48 start-page: 381 year: 1990 ident: 52_CR37 publication-title: Pharmacol Ther doi: 10.1016/0163-7258(90)90056-8 contributor: fullname: WB Parker |
SSID | ssj0020766 |
Score | 2.269708 |
Snippet | Studies showed the positive effects of omega-3 fatty acid (n-3 FA) for the treatment of inflammatory bowel disease as it alleviated the symptoms and promoted... Background Studies showed the positive effects of omega-3 fatty acid (n-3 FA) for the treatment of inflammatory bowel disease as it alleviated the symptoms and... |
SourceID | pubmedcentral gale crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 54 |
SubjectTerms | Animals Apoptosis - drug effects Dietary Supplements Escherichia coli - metabolism Fatty Acids, Omega-3 - pharmacology Fatty Acids, Omega-3 - therapeutic use Fluorouracil - adverse effects Health aspects Ileum - drug effects Ileum - pathology Injections Intestinal Mucosa - drug effects Intestinal Mucosa - pathology Mice Mice, Inbred BALB C Mucositis - chemically induced Mucositis - drug therapy Permeability - drug effects Weight Loss - drug effects |
SummonAdditionalLinks | – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3fa9swED7SFsZeyvprS9cOPYwWCloz64flhzFC11AG7VMDfTOyLG2BxGkTB5r89b2znVBDC36yZAv0nXT6pNN3AN-liYIJ1nKVZIqjUeTcqpBx4VxOeihWVrf4b-_0zVD-fVAPHVint2o6cP4mtaN8UsPZ-Mfz0_I3Dvhf1YA3-nKOPktSLIXitMvJV1uwE0kk6hTJJzeHChFSdt0cbL75GQkDa9KgUqLlpZq5euOh2tGTr9zR4BPsNutI1q-B34OOL_bhoF8gh54s2RmrIjurLfN9-HDbHKAfgPsz8qWdLdmcsnnWkeMEDaP9WDad-H-WCxZsWS6ZdaOckfxmsaAFKVM8jBfTGbaMJWOGZB7NImcTinknZSR8wyi5_SEMB9f3Vze8ybPAnRK65Enieh6ZFPLqSIfgc5PJGGmelUH4BF8Hom3Gasq1rn5mNo-Di3J8IuslrgeOYLuYFv4LMB33dBJEEIny0miV9RITZ8qY3OJEkSVduFj3a_pYy2mkFQ0xOq3xSBGPlPBIV104p55PCXzsaWebGwPYFIlWpX1KYY6TtRZdOGnVxCHiWsWfa8g2ba5x7kLcAnNTgVS32yXF6H-lvi1lLEwUH7_7z6_wMaqMihIcncB2OVv4U1y5lNm3yh5fACDp6uA priority: 102 providerName: Scholars Portal |
Title | Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26063053 https://pubmed.ncbi.nlm.nih.gov/PMC4473827 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEB2SHEovpUn6sUkadCgtFJTdWB-Wj0vaEApbemggNyPJUruw9oaN97D59Z2R7aW-FowPko2M3kijJ4_eAHyUJosmWstV4RRHo6i4VdFx4X1FeihWplP8ix_67l5-f1APB6CGszApaN-75VWzqq-a5Z8UW_lY--kQJzb9ubiRMhcGOfshHKKBDhS9Z1lIzHX_-_La6OkTOjRJgRaK0xYofyb5X01KU0qMfFE_I-_90DhG8h-nc_saXvWrRTbvvuoYDkJzAqfzBplyvWOfWIrfTBvjJ_Bi0f8mPwX_dRlau9mxJ8rZ2cWHEwCMdl3Zug6_LRcs2rbdMeuXFSORzWZLy06meFxt1xtsGWtWDCk7gl-xmiLbSf8ISxilsH8D97ffft3c8T6bAvdK6JYXhZ8F5EvInjMdY6iMkzmSOSujCAUWRyJnxmrKqK6una3y6LMKr8wGiV7_LRw16ya8B6bzmS6iiKJQQRqt3KwwuVPGVBanA1dM4MvQr-VjJ5pRJrJhdNnhUSIeJeFRPk_gM_V8SQMKe9rb_lwANkXSVOWcEpXjlKzFBC5GT-JA8KPqdx1k-zYHnCeQj8DcP0Da2uMaNLmksd2b2Nl_v3kOL7NkdJTm6AKO2s02fMD1S-suE-_H-0Kay2S7fwG5b_Km |
link.rule.ids | 230,315,730,783,787,867,888,24330,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFL0aQwJe-NgYFAb4AYGE5LZrbMd5rAZTgXXiYUN7i2zHhogmnbr0of313JuPivAGUp7iRE50rj-OfXwuwFuhJ0EHY7hMrOQYFBk3MlgeOZeRH4oR9Sn--YWaXYkv1_J6D2R3FqYW7TubD8tFMSzzn7W28qZwo04nNvo2PxUijjRy9jtwF9vrWHQkveVZSM1Vu4F5otXoFoc0QVILyWkRlG_JAFiR15SMeqNR2yfvRqK-SvKPYefsEXzvPrhRm_waris7dNu_vBz_-Y8ew8N2IsqmTfET2PPlARxOSyThxYa9Y7U0tF5zP4B783YH_hDcx9xXZrVht5QOtJGeE7aMFnTZsvA_DI9YMFW1YcblGSP_znJNM1omeVislyusGUsWLC8zjKuMFSSaJ2slvMMK7LiewtXZp8vTGW8TNXAnI1XxJHFjj1QMiflEheAzbUWMPNGIEPkEbwfifdooStYuT6zJ4uAmGV4T4wVOKI5gv1yW_jkwFY9VEqIQJdILraQdJzq2UuvMYE9jkwF86ABLbxo_jrTmMVqlDdApAp0S0Ol2AO8J0pTaKkLoTHvkAKsi16t0SjnQsbdX0QCOe09iG3O94mdNLOzq7AJoAHEvSnYPkG13vwSxr-27W6xf_Pebb-D-7HJ-np5_vvj6Eh5M6simbErHsF-t1v4VTpMq-7puFL8Beb0S3w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLVgSBMvAzYuHQP8gEBCctsltuM8VhvVuHTaA5MmXiJfR0STVl360P56vi-XauFxUp5iR050Pl-OfXI-Qj5yFQUVtGYiNYJBUDimRTAsttahH4rm9V_8s0t5cc2_34ibe6m-atG-NfmwnBfDMv9TayuXhR11OrHR1eyM8yRWwNmXLowekyfQZ8eyI-ot1wJ6LttDzFMlR3cwrXGUWwiGG6FsiybAEv2mRNybkdpxeTcb9ZWS96ae6TPyu3vpRnHyd7iuzNBu__NzfNBXPScH7YKUTpoqL8gjXx6So0kJZLzY0E-0lojWe--HZH_WnsQfEXue-0qvNvQO04I2EnTEmOLGLl0U_lazmAZdVRuqbe4o-niWa1zZUsHCfL1YQctQMqd56SC-HC1QPI8WS3CHFjCAvSTX06-_zi5Ym7CBWRHLiqWpHXugZEDQIxmCd8rwBPii5iH2KdwOyP-Ulpi0XZwa7ZJgIwdXpD2HhcUrslcuSv-GUJmMZRriEKfCcyWFGacqMUIpp2HEMemAfOlAy5aNL0dW8xklswbsDMDOEOxsOyCfEdYM-yzAaHX76wE0he5X2QRzocOoL-MBOenVhL5me8Wvm3jYtdkF0YAkvUjZVUD77n4J4F_beLd4Hz_4yQ9k_-p8mv38dvnjLXka1cGNSZVOyF61Wvt3sFqqzPu6X_wDFJ8VXw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dietary+supplementation+with+omega-3+fatty+acid+attenuates+5-fluorouracil+induced+mucositis+in+mice&rft.jtitle=Lipids+in+health+and+disease&rft.au=Generoso%2C+Simone+de+Vasconcelos&rft.au=Rodrigues%2C+N%C3%BAbia+Morais&rft.au=Trindade%2C+Lu%C3%ADsa+Martins&rft.au=Paiva%2C+Nivea+Carolina&rft.date=2015-06-12&rft.eissn=1476-511X&rft.volume=14&rft.spage=54&rft_id=info:doi/10.1186%2Fs12944-015-0052-z&rft_id=info%3Apmid%2F26063053&rft.externalDocID=26063053 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon |